Fig. 2From: Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityThe serum levels of triglycerides (a), total cholesterol (b), LDL (c) and HDL (d) in the sham, AS and EMPA groups. AS, atherosclerosis group; EMPA, empagliflozin group. One-way analysis of variance with the Bonferroni post hoc test was used. n = 6, *P<0.05, ** P<0.01, *** P<0.001Back to article page